Active Challenges

Menterra Impact Challenges - Healthcare 1

Healthcare in India is plagued by the "Iron Triangle" of Access, Cost and Quality. Apart from access, one of the major concerns is affordability. In such a scenario, enterprises with stand-alone digital solutions emerge as a pivotal point in assisting people in managing their health concerns and delivering value-based care in the healthcare continuum in India.

About the Challenge

Access to quality healthcare remains within the hands of a select few. To bridge this growing gap, we drive change through:

Healthcare in India is plagued by the “Iron Triangle” of Access, Cost and Quality. Apart from access, one of the other major concerns, therefore, is affordability. Covid-19 has further highlighted the gaps in the system and the chasm between the urban and rural centers.

The applications launched on Friday, September 16, 2022 and closed on Friday, October 14, 2022. The awards announcement took place at the end of December 2022.

Apply Now

Challenge Themes

Early Screening and Diagnosis

Solutions for early detection and diagnosis of cancer, and improvement of diagnostic accuracy in differentiating cancer from other medical conditions precluding its undetected progression to advanced stages.

Improving Access

Solutions that improve access to high-quality onco-surgery and radiation therapy by enabling more surgeries and radiation, employing novel methods of delivering treatment, and improving upon current practices by reducing in-treatment errors and post-treatment complications.

Recovery & Rehabilitation

Improvement in the quality of and new solutions for rehabilitation and recovery, use of dietary and other interventions to alleviate side effects and/or to boost the efficacy of treatment, and improvement in palliative care.

Focus Areas

Low Resource

Innovation is low resource setting


Solutions that can be deployed at scale


Ensure increased access across geographies


Bring hitherto unaffordable solutions to the larger population


Menterra will further facilitate Indian innovators by offering recognition, financial and field validation support to them required for combating the challenges of the healthcare system. The selected businesses will receive:

An initial investment of up to

₹3 crores in businesses by Menterra

for investment candidates

Equity investment of up to

₹50 lakhs for incubation Candidates

Participation in an incubation program to deliver

Commercial milestones to unlock

a larger follow-on funding from Menterra

Who Can Join?

We’re looking for promising early-stage Indian businesses or start-ups in the oncology space.

  • With truly differentiated products, innovative technologies and business models.
  • Working to increase access to quality and affordable healthcare.
  • Improving health outcomes for underserved communities.
  • Addressing the changing disease burden and emerging global health priorities.

Challenge Partner

For more details, write to us at

Digital Healthcare Challenge

Digital health technologies are pivotal for delivering value-based care across the healthcare continuum in India. Adaptive intelligent solutions can help lower the barriers between hospitals and patients, improve access to care, and enhance overall patient satisfaction, particularly in tier II and tier III cities.

Challenge Winner

Through our Digital Healthcare Challenge, we received 76 applications from companies developing breakthrough technologies. The applications went through 3 rounds of detailed screening by the Menterra team and industry experts. After 3 months of rigorous assessment, TeraLumen was selected as the winner of this challenge.

Abhishek Sen & Yogesh Patel

TeraLumen is developing India’s first Artificial Intelligence (AI)-enabled, Terahertz-based intraoperative device for real-time cancer margin detection. This technology significantly improves on existing cancer margin detection practices and reduces time by ~75% for a patient under anaesthesia and in surgery. The current use case has been developed for breast cancer. There are possible larger opportunities in more critical cancer areas such as brain cancer that require precise cancer margin detection.